An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD
- First Posted Date
- 2014-08-29
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- FerruMax Pharmaceuticals, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT02228655
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD
- First Posted Date
- 2013-06-10
- Last Posted Date
- 2015-08-11
- Lead Sponsor
- FerruMax Pharmaceuticals, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT01873534
- Locations
- 🇺🇸
DaVita Arvada Dialysis Center, Arvada, Colorado, United States
🇺🇸DaVita Minneapolis Dialysis Unit, Minneapolis, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath